Molecular monitoring of residual disease using antigen receptor genes in childhood acute lymphoblastic leukaemia
- 31 March 2002
- journal article
- review article
- Published by Elsevier in Best Practice & Research Clinical Haematology
- Vol. 15 (1), 37-57
- https://doi.org/10.1053/beha.2002.0184
Abstract
No abstract availableKeywords
This publication has 80 references indexed in Scilit:
- Prognostic value of minimal residual disease in relapsed childhood acute lymphoblastic leukaemiaThe Lancet, 2001
- Real-time quantitative PCR for detection of minimal residual disease before allogeneic stem cell transplantation predicts outcome in children with acute lymphoblastic leukemiaLeukemia, 2001
- Minimal residual disease in leukaemia patientsThe Lancet Oncology, 2001
- Primers and protocols for standardized detection of minimal residual disease in acute lymphoblastic leukemia using immunoglobulin and T cell receptor gene rearrangements and TAL1 deletions as PCR targets Report of the BIOMED-1 CONCERTED ACTION: Investigation of minimal residual disease in acute leukemiaLeukemia, 1999
- Prognostic value of minimal residual disease in acute lymphoblastic leukaemia in childhoodThe Lancet, 1998
- Minimal residula disease status as a predictor of relapse after allogenic bone marrow transplantation for children with acute lymphoblastic leukaemiaBritish Journal of Haematology, 1998
- Monitoring minimal residual disease in peripheral blood in B‐lineage acute lymphoblastic leukaemiaBritish Journal of Haematology, 1997
- T-cell antigen receptor genes and T-cell recognitionNature, 1988
- Die Corticosteroid-abhängige Dezimierung der Leukämiezellzahl im Blut als Prognosefaktor bei der akuten lymphoblastischen Leukämie im Kindesalter (Therapiestudie ALL-BFM 83)Klinische Padiatrie, 1987
- Somatic generation of antibody diversityNature, 1983